Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2023 | The role of molecular biomarkers in determining patient response to bladder cancer treatment

Elizabeth R. Plimack, MD, MS, Fox Chase Cancer Centre, Philadelphia, PA, discusses the current role of molecular biomarkers in assessing a patient’s response to bladder cancer treatment. Furthermore, Dr. Plimack explores the prospective advancements and application of these biomarkers. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.